Back

Discussion - COMPASS CHF

28 May 2018 (17:10 - 17:15)
Organised by:
Congress Presentation Part of: Late breaking trial IV - Registries Chronic Heart Failure, Other HFA Premium Access Heart Failure 2018

11 More presentations in this session

Presentation thumbnail
Association between sacubitril/valsartan initiation and health status outcomes in heart failure with reduced ejection fraction: findings from the CHAMP-HF registry
Doctor Y. Khariton (Kansas City, US)
Slides Video
Presentation thumbnail
Discussion - Sacubitril/Valsartan initiation and health status outcomes in HFrEF
Video
Presentation thumbnail
Subtle ventricular dysfunction outperforms other risk markers in patients with coronary artery disease
Professor D. Kotecha (Birmingham, GB)
Slides Video
Presentation thumbnail
Discussion - ARM-CAD
Video
Presentation thumbnail
Rivaroxaban plus aspirin in patients with and without heart failure and chronic coronary or peripheral artery disease: the COMPASS trial
Professor K. Branch (Seattle, US)
Slides Video

Access the full session

Session thumbnail
Late breaking trial IV - Registries

The Event

Event poster

Heart Failure 2018

28 May 2018 17:10 CET
You may be interested in
thumbnail
Congress Session
Treatment of cardiovascular comorbidities in patients with heart failure
17 May 2025
thumbnail
Congress Presentation
Refinement of a multicomponent nurse intervention for multidisciplinary care in Heart Failure: results from a formal consensus development technique study
13 June 2025
thumbnail
Congress Session
Debate on primary prevention in ICD therapy
30 March 2025
thumbnail
Congress Presentation
Congenital course: basics and great vessels - discussion
11 December 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources